Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06124521

Community Based Treatment for (ComBaT) Glaucoma

The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access to care.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan, Ann Arbor, Michigan, United States

Loading trial locations.

About this study

Outcome measures related to acceptability and feasibility are exploratory. They will not be registered or results reported.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Black or African American
  • Participated in the screening examination portion of the study

Exclusion criteria

  • Current eye pain (> 8 out of 10)
  • Sudden decrease in vision (within 1 week)
  • Double vision that doesn't stop when you blink and stops no matter what eye you cover (not blurred, but seeing 2 objects)
  • Pregnant women
  • Prisoners
  • Cognitive impairment- unable to give an ocular and social history
  • Moving outside of Michigan or driving distance to the church within 6 months

Treatment and study plan

ComBaT Glaucoma

Behavioral

ComBaT Glaucoma is a personalized counseling and education program about the participant's diagnosis and the importance of glaucoma follow-up care in maintaining vision.

Primary outcomes

  1. Eye care utilization

    Time frame: Up to 14 months

    Participants who have not seen an eye care provider for an initial clinical evaluation within 6 months of entering the program or a follow-up evaluation at 12 months will be considered underutilizers. Those who have received evaluation at 6 and 12 months will be considered normal utilizers.

Study contacts

Contact information is provided by the study sponsor or research team.

Phalatha McHaney-Conner, BS

CONTACT

[email protected]

734-945-6046

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Official study title

Increasing Eye Care Utilization in Black Americans At High Risk For Glaucoma Using A Community-Engaged and Faith-Based Intervention

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Nov 9, 2023
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.